Naltrexone in the Treatment of Alcohol Dependence

Cited by (618)

Items 101–200 of 618

1. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
   H. Pettinati, K. Kampman, K. Lynch, Jesse J. Suh, C. Dackis, D. Oslin, C. O'Brien · 2008 · Journal of Substance Abuse Treatment
2. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials
   Davit Khachatryan, Dianne Groll, Linda Booij, Amir A. Sepehry, Christian G. Schütz · 2015 · General Hospital Psychiatry
3. Naltrexone Implant for the Treatment of Polydrug Dependence: A Randomized Controlled Trial
   Jari Tiihonen, Evgeny M. Krupitsky, Elena V. Verbitskaya, Elena A. Blokhina, Olga Mamontova, Jaana Föhr, Pekka Tuomola, Kimmo I. Kuoppasalmi, Vesa V. Kiviniemi, Edwin E. Zvartau · 2012 · American Journal of Psychiatry
4. Targeted Naltrexone for Early Problem Drinkers
   Henry R. Kranzler, Stephen Armeli, Howard A. Tennen, Ola Blomqvist, Cheryl A. Oncken, Nancy M. Petry, Richard Feinn · 2003 · Journal of Clinical Psychopharmacology
5. Buprenorphine Reduces Alcohol Drinking Through Activation of the Nociceptin/Orphanin FQ-NOP Receptor System
   Roberto Ciccocioppo, Daina Economidou, Roberto Rimondini, Wolfgang H. Sommer, Maurizio Massi, Markus A Heilig · 2006 · Biological Psychiatry
6. A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence
   Hendrik G. Roozen, Ranne de Waart, Daniëlle van der Windt, Wim van den Brink, C.A.J. de Jong, A.J.F.M. Kerkhof · 2005 · European Neuropsychopharmacology
7. A Clinical Laboratory Paradigm for Evaluating Medication Effects on Alcohol Consumption: Naltrexone and Nalmefene
   David J. Drobes, Raymond F. Anton, Suzanne E Thomas, Konstantin E. Voronin · 2002 · Neuropsychopharmacology
8. Searching for Responders to Acamprosate and Naltrexone in Alcoholism Treatment: Rationale and Design of thePredict Study
   Karl F Mann, Falk Kiefer, Michael N. Smolka, Horst Gann, Stefan Wellek, Andreas Heinz · 2009 · Alcoholism Clinical and Experimental Research
9. Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?
   Mann, Karl, Aubin, Henri-Jean, Witkiewitz, Katie · 2017 · European Addiction Research
10. Medications for substance use disorders
    Douaihy, Antoine B., Kelly, Thomas M., Sullivan, Carl · 2013 · Social Work in Public Health
11. A Randomized, Double‐Blind, Placebo‐Controlled Pilot Study of Naltrexone in Outpatients With Bipolar Disorder and Alcohol Dependence
    E. Sherwood Brown, Thomas James Carmody, Joy M. Schmitz, Raúl Caetano, Bryon H. Adinoff, Alan C. Swann, Augustus John Rush · 2009 · Alcoholism Clinical and Experimental Research
12. A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients
    Sung‐Gon Kim, Cheol-Min Kim, Sam‐Wook Choi, Young-Myo Jae, Hae-Gook Lee, Bongki Son, Jeong‐Gee Kim, Young-Sung Choi, Han-Oh Kim, Seong‐Yeon Kim et al. · 2008 · Psychopharmacology
13. CLINICAL PREDICTORS OF RESPONSE TO NALTREXONE IN ALCOHOLIC PATIENTS: WHO BENEFITS MOST FROM TREATMENT WITH NALTREXONE?
    Gabriel Rubio, Guillermo Ponce, Roberto Rodríguez–Jiménez, Miguel Ángel Jiménez‐Arriero, Janet Hoenicka, Tomás Palomo · 2005 · Alcohol and Alcoholism
14. Endogenous Opioid Blockade and Impulsive Responding in Alcoholics and Healthy Controls
    Jennifer Mitchell, Venessa C. Tavares, Howard L. Fields, Mark D’Esposito, Charlotte A. Boettiger · 2006 · Neuropsychopharmacology
15. Psychotic Spectrum Disorders and Alcohol Abuse: A Review of Pharmacotherapeutic Strategies and a Report on the Effectiveness of Naltrexone and Disulfiram
    Ismene L. Petrakis, Charla Nich, Elizabeth Ralevski · 2005 · Schizophrenia Bulletin
16. Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala
    Marisa Roberto, George R. Siggins · 2006 · Proceedings of the National Academy of Sciences
17. Denying autonomy in order to create it: the paradox of forcing treatment upon addicts
    Arthur L. Caplan · 2008 · Addiction
18. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence
    Badreddine Bencherif, Gary S. Wand, Mary Elizabeth McCaul, Yu Kyeong Kim, Nese Ilgìn, Robert F. Dannals, J. James Frost · 2004 · Biological Psychiatry
19. Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?
    Mark Egli · 2005 · Addiction Biology
20. Baclofen Blocks Expression and Sensitization of Anxiety‐Like Behavior in an Animal Model of Repeated Stress and Ethanol Withdrawal
    Darin J. Knapp, David H. Overstreet, George R. Breese · 2007 · Alcoholism Clinical and Experimental Research
21. OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype‐Based Approach
    Gábor Oroszi, Raymond F. Anton, Stephanie S. O’Malley, Robert M. Swift, Helen M. Pettinati, David J. Couper, Qiaoping Yuan, David A Goldman · 2008 · Alcoholism Clinical and Experimental Research
22. Impact of Continuing Care on Recovery From Substance Use Disorder
    James R. McKay · 2021 · Alcohol research
23. Pharmacotherapy for pregnant women with addictions
    William F. Rayburn, Michael P. Bogenschutz · 2004 · American Journal of Obstetrics and Gynecology
24. Pharmacological approaches to reducing craving in patients with alcohol use disorders
    Haass-Koffler, Carolina L., Leggio, Lorenzo, Kenna, George A. · 2014 · CNS Drugs
25. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia
    John Harrison Krystal, Deepak Cyril D’Souza, Jürgen Gallinat, Naomi R Driesen, Anissa Abi‐Dargham, Ismene L. Petrakis, Andreas Heinz, Godfrey D. Pearlson · 2006 · Neurotoxicity Research
26. Prolonged Central μ-Opioid Receptor Occupancy after Single and Repeated Nalmefene Dosing
    Kimmo Ingman, Nora M. Hagelberg, Sargo Aalto, Kjell Någren, Auni Juhakoski, Sakari Karhuvaara, Antero Kallio, Vesa Oikonen, Jarmo A. Hietala, Harry Scheinin · 2005 · Neuropsychopharmacology
27. Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial
    Giovanni Martinotti, Marco Di Nicola, Daniela Tedeschi, S. Andreoli, Daniela Reina, M. Pomponi, Marianna Mazza, R. Romanelli, N. Moroni, Rocco de Filippis et al. · 2009 · Journal of Psychopharmacology
28. A Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long‐Acting Injectable Naltrexone (Vivitrex®) in Patients With Alcohol Dependence
    Bankole A. Johnson, Nassima Ait‐Daoud, Henri‐Jean Aubin, Wim van den Brink, Richard V. Guzzetta, John W. Loewy, Bernard L. Silverman, Elliot W. Ehrich · 2004 · Alcoholism Clinical and Experimental Research
29. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants
    Nassima Ait‐Daoud, Robert J Malcolm, Bankole A. Johnson · 2006 · Addictive Behaviors
30. The Pharmacogenetics of Alcohol Use Disorder
    Jermaine D. Jones, Sandra D. Comer, Henry R. Kranzler · 2015 · Alcoholism Clinical and Experimental Research
31. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism
    Michael Soyka, Henry R. Kranzler, Mats Berglund, David A. Gorelick, VICTOR M. HESSELBROCK, Bankole A. Johnson, Hans‐Jürgen Möller, THE WFSBP TASK FORCE ON TREATMENT G · 2008 · The World Journal of Biological Psychiatry
32. Treating alcoholism as a chronic disease: approaches to long-term continuing care.
    James R. McKay, Susanne Hiller-Sturmhöfel · 2011 · Europe PMC (PubMed Central)
33. Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study
    Fabio Caputo, Giovanni Addolorato, Francesca Lorenzini, Marco Domenicali, G. Greco, Arfedele Del Re, Antonio Gasbarrini, Giuseppe Francesco Stefanini, Mauro Bernardi · 2003 · Drug and Alcohol Dependence
34. Comparative Effectiveness Research: What Kind of Studies Do We Need?
    John Concato, Peter N. Peduzzi, Grant D. Huang, Timothy J. O’Leary, Joel Kupersmith · 2010 · Journal of Investigative Medicine
35. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment
    Mason, Barbara J. · 2003 · European Neuropsychopharmacology
36. Treatment modalities for patients with gambling disorder
    Sam‐Wook Choi, Young Chul Shin, Dai‐Jin Kim, Jung‐Seok Choi, Seohee Kim, Seung-Hyun Kim, HyunChul Youn · 2017 · Annals of General Psychiatry
37. Beliefs about evidence-based practices in addiction treatment: A survey of Veterans Administration program leaders
    Mark L Willenbring, Daniel R. Kivlahan, Marie E. Kenny, Michael Grillo, Hildi Hagedorn, Andrea C Postier · 2004 · Journal of Substance Abuse Treatment
38. The Effect of Naltrexone on Alcohol’s Stimulant Properties and Self‐Administration Behavior in Social Drinkers: Influence of Gender and Genotype
    Elaine Setiawan, Robert O. Pihl, Sylvia M. L. Cox, Christina Gianoulakis, Roberta M. Palmour, Chawki Benkelfat, Marco Leyton · 2011 · Alcoholism Clinical and Experimental Research
39. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial
    Péter Hauser, Bret E. Fuller, Samuel B. Ho, PAUL D. THURAS, Shira M. Kern, Eric W. Dieperink · 2017 · Addiction
40. Variable selection for qualitative interactions
    Lacey Gunter, Ji Zhu, Susan A. Murphy · 2009 · Statistical Methodology
41. The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration
    Subhashini Srinivasan, Jeffrey A. Simms, Carsten Krogh Nielsen, Steven P. Lieske, Jade J. Bito‐Onon, Henry Y. Yi, Frederic Woodward Hopf, Antonello Bonci, Selena E. Bartlett · 2012 · PLoS ONE
42. Personalized Treatment of Alcohol Dependence
    Henry R. Kranzler, James R. McKay · 2012 · Current Psychiatry Reports
43. Nociceptin/Orphanin FQ Blockade of Corticotropin-Releasing Factor-Induced Gamma-Aminobutyric Acid Release in Central Amygdala Is Enhanced After Chronic Ethanol Exposure
    Maureen T. Cruz, Melissa A. Herman, Marsida Kallupi, Marisa Roberto · 2011 · Biological Psychiatry
44. The Effect of Aripiprazole on Cue-Induced Brain Activation and Drinking Parameters in Alcoholics
    Hugh Myrick, Xingbao Li, Patrick K. Randall, Scott Henderson, Konstantin E. Voronin, Raymond F. Anton · 2010 · Journal of Clinical Psychopharmacology
45. Intramuscular extended‐release naltrexone: current evidence
    Gastfriend, David R. · 2011 · Annals of the New York Academy of Sciences
46. New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence
    Falk Kiefer, Karl F Mann · 2005 · European Journal of Pharmacology
47. Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study
    Lara A. Ray, Spencer Bujarski, Pauline F. Chin, Karen A. Miotto · 2011 · Neuropsychopharmacology
48. Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers
    Albert J. Arias, Stephen Armeli, Joel E. Gelernter, Jonathan Covault, Antero Kallio, Sakari Karhuvaara, Tiina Koivisto, Rauno Mäkelä, Henry R. Kranzler · 2008 · Alcoholism Clinical and Experimental Research
49. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: A preliminary study.
    Spencer Bujarski, James M. MacKillop, Lara A. Ray · 2012 · Experimental and Clinical Psychopharmacology
50. Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors
    Rachel Cant, Angus George Dalgleish, Rachel Louise Allen · 2017 · Frontiers in Immunology
51. Advances in the Use of Naltrexone an Integration of Preclinical and Clinical Findings
    Stephanie S. O’Malley, Janice C. Froehlich · 2002 · Springer eBooks
52. The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism
    Wand, G. · 2005 · Journal of Clinical Investigation
53. Adherence Monitoring in Naltrexone Pharmacotherapy Trials: A Systematic Review
    Robert M. Swift, David W. Oslin, Mark Alexander, Robert F. Forman · 2011 · Journal of Studies on Alcohol and Drugs
54. A Cluster Randomized Controlled Trial of an Adolescent HIV Prevention Program Among Bahamian Youth: Effect at 12 Months Post-Intervention
    Xinguang Chen, Sonja Lunn, Lynette Deveaux, Xiaoming Li, Nanika V. Brathwaite, Lesley Cottrell, BONITA F. STANTON · 2008 · AIDS and Behavior
55. Vivitrex®, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for 1 Month in Rats
    Raymond T. Bartus, Dwaine F. Emerich, Joyce Hotz, M. Blaustein, Reginald L. Dean, Brigido Perdomo, Anthony S. Basile · 2003 · Neuropsychopharmacology
56. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics
    Wendy Ooteman, Maarten W.J. Koeter, Roel Verheul, Gerard M. Schippers, Wim van den Brink · 2007 · European Neuropsychopharmacology
57. Current Pharmacotherapies of Alcoholism: A U.S. Perspective
    Raymond F. Anton, Robert M. Swift · 2003 · American Journal on Addictions
58. Naltrexone: A Pan-Addiction Treatment?
    Elias N. Aboujaoude, Wael O. Salame · 2016 · CNS Drugs
59. A Placebo‐Controlled Randomized Clinical Trial of Naltrexone in the Context of Different Levels of Psychosocial Intervention
    David W. Oslin, Kevin G. Lynch, Helen M. Pettinati, Kyle Matthew Kampman, Peter Gariti, Lois A. Gelfand, Thomas Ten Have, Shoshana P. Wortman, William D. Dundon, Charles A. Dackis et al. · 2008 · Alcoholism Clinical and Experimental Research
60. A Randomized, Double‐Blind, Placebo‐Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Use Disorder and Pathological Gambling
    Tony Toneatto, Bruna Brands, Peter L. Selby · 2009 · American Journal on Addictions
61. The Cambridge Handbook of Substance and Behavioral Addictions
    Steve Y. Sussman · 2020 · Cambridge University Press eBooks
62. PTSD and comorbid AUD: a review of pharmacological and alternative treatment options
    Ismene L. Petrakis, Elizabeth Ralevski, Lening Alexis Olivera-Figueroa · 2014 · Substance Abuse and Rehabilitation
63. Pharmacogenetics of Alcohol and Alcohol Dependence Treatment
    Henry R. Kranzler, Howard J. Edenberg · 2010 · Current Pharmaceutical Design
64. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative study
    Fabio Caputo, Giovanni Addolorato, Michela Stoppo, Sara Francini, Teo Vignoli, Francesca Lorenzini, Arfedele Del Re, Claudio Comaschi, Pietro Andreoné, Franco Trevisani et al. · 2007 · European Neuropsychopharmacology
65. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models
    Megan M. Yardley, Lara A. Ray · 2016 · Addiction Biology
66. Effectiveness of Naltrexone in a Community Treatment Program
    Therese K. Killeen, Kathleen T. Brady, Paul B. Gold, Kit N. Simpson, Richard A. Faldowski, Clare Tyson, Raymond F. Anton · 2004 · Alcoholism Clinical and Experimental Research
67. The Placebo Effect in Clinical Trials for Alcohol Dependence: An Exploratory Analysis of 51 Naltrexone and Acamprosate Studies
    Raye Z. Litten, I‐Jen P. Castle, Daniel E. Falk, Megan Ryan, Joanne B. Fertig, Chiung M. Chen, Hsiao‐ye Yi · 2013 · Alcoholism Clinical and Experimental Research
68. Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: A randomized placebo-controlled trial
    Kathleen M. Carroll, Charla Nich, Julia M. Shi, Dorothy A. Eagan, Samuel A. Ball · 2012 · Drug and Alcohol Dependence
69. Habit formation: Implications for alcoholism research
    David S. O'Tousa, Nicholas J. Grahame · 2014 · Alcohol
70. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol
    James R. Ashenhurst, Spencer Bujarski, Lara A. Ray · 2012 · Pharmacology Biochemistry and Behavior
71. Testing Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (The COMBINE Study): A Pilot Feasibility Study
    The COMBINE Study Research Group · 2003 · Alcoholism Clinical and Experimental Research
72. Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis
    Clément Palpacuer, Karima Hammas, Renan Duprez, Bruno Laviolle, John P. A. Ioannidis, Florian Naudet · 2019 · BMC Medicine
73. Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism
    John Harrison Krystal, Steven H. Madonick, Edward Belk Perry, Ralitza V. Gueorguieva, Laura Brush, Yola Wray, Ayşenil Belger, Deepak Cyril D’Souza · 2006 · Neuropsychopharmacology
74. A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
    Erin J. Campbell, Nathan J. Marchant, Andrew John Lawrence · 2018 · Brain Research
75. Choosing a behavioral therapy platform for pharmacotherapy of substance users
    Kathleen M. Carroll, Thomas R. Kosten, Bruce J. Rounsaville · 2004 · Drug and Alcohol Dependence
76. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats
    Jason E. Gallate, Paul E. Mallet, Iain S. McGregor · 2004 · Psychopharmacology
77. The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat
    Michael F. Stromberg · 2004 · Pharmacology Biochemistry and Behavior
78. Effect of extended‐release naltrexone on alcohol consumption: a systematic review and meta‐analysis
    Charles E. Murphy, Ralph C. Wang, Juan Carlos C. Montoy, Evans Whittaker, Maria C. Raven · 2021 · Addiction
79. Effect of Extended‐Release Naltrexone (XR‐NTX) on Quality of Life in Alcohol‐Dependent Patients
    Helen M. Pettinati, David R. Gastfriend, Qunming Dong, Henry R. Kranzler, Stephanie S. O’Malley · 2008 · Alcoholism Clinical and Experimental Research
80. Preclinical and clinical pharmacology of alcohol dependence
    Sophie Tambour, Étienne Quertemont · 2006 · Fundamental and Clinical Pharmacology
81. Differences in the Peripheral Levels of ??-endorphin in Response to Alcohol and Stress as a Function of Alcohol Dependence and Family History of Alcoholism
    Xing Dai, Joseph Thavundayil, Christina Gianoulakis · 2005 · Alcoholism Clinical and Experimental Research
82. A categorical typology of naltrexone-adopting private substance abuse treatment centers
    Carrie B. Oser, Paul Michael Roman · 2007 · Journal of Substance Abuse Treatment
83. Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study
    Ralitza V. Gueorguieva, Ran Wu, Dennis M. Donovan, Bruce J. Rounsaville, David J. Couper, John Harrison Krystal, Stephanie S. O’Malley · 2009 · Drug and Alcohol Dependence
84. From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy
    George Bradley Richerson, Detlev Boison, Carl L. Faingold, Philippe Ryvlin · 2016 · Epilepsia
85. Pharmacotherapy for Alcohol Dependence: Anticraving Medications for Relapse Prevention
    Young‐Chul Jung, Kee Namkoong · 2006 · Yonsei Medical Journal
86. Practitioner Review: Adolescent alcohol use disorders: assessment and treatment issues
    Francheska Perepletchikova, John Harrison Krystal, Joan Kaufman · 2008 · Journal of Child Psychology and Psychiatry
87. Behavioral Economic Considerations of Novel Addictions and Nonaddictive Behavior: Research and Analytic Methods
    Derek D. Reed, Gideon P. Naudé, Brett W. Gelino, Michael T Amlung · 2020 · Cambridge University Press eBooks
88. A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers
    Scott E. Lukas, David M. Penetar, Zhaohui Su, Thomas R. Geaghan, Melissa A. Maywalt, Michael Tracy, John M. Rodolico, Christopher Palmer, Zhongze Ma, David Y.W. Lee · 2012 · Psychopharmacology
89. Eating Disorders and Alcohol Use Disorders
    Carlos M. Grilo, Rajita Sinha, Stephanie S. O’Malley · 2002 · Europe PMC (PubMed Central)
90. Pruritus and fatigue in primary biliary cirrhosis
    Nora V. Bergasa · 2003 · Clinics in Liver Disease
91. New Insights into the Efficacy of Naltrexone Based on Trajectory-Based Reanalyses of Two Negative Clinical Trials
    Ralitza V. Gueorguieva, Ran Wu, Brian P. Pittman, Joyce A. Cramer, Robert Alan Rosenheck, Stephanie S. O’Malley, John Harrison Krystal · 2007 · Biological Psychiatry
92. New steps for treating alcohol use disorder
    Erin J. Campbell, Andrew John Lawrence, Christina J. Perry · 2018 · Psychopharmacology
93. The Efficacy of Acamprosate and Naltrexone in the Treatment of Alcohol Dependence: A Relative Benefits Analysis of Randomized Controlled Trials
    James L. Snyder, Thomas G. Bowers · 2008 · The American Journal of Drug and Alcohol Abuse
94. Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013
    Scott H. Waltman, David S. Shearer, Bret A. Moore · 2018 · Current Psychiatry Reports
95. Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala
    Bihua Bie, W. Zhu, Zhizhong Z. Pan · 2009 · Neuroscience
96. Topiramate for Alcohol Dependence
    Christina L Olmsted, Denise R Kockler · 2008 · Annals of Pharmacotherapy
97. Acamprosate in the treatment of alcohol dependence
    Barbara J. Mason · 2005 · Expert Opinion on Pharmacotherapy
98. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
    Gantt P. Galloway, Monika Koch, Ryan Cello, David E. Smith · 2005 · BMC Psychiatry
99. Neurobiological Foundations of Behavioral Addictions
    Anthony G. Vaccaro, Marc N. Potenza · 2020 · Cambridge University Press eBooks
100. The Prevention and Treatment of Gambling Disorders: Some Art, Some Science
     Jeffrey Lee Derevensky · 2020 · Cambridge University Press eBooks